Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today unveiled findings from a survey conducted by The Harris...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ Intraosseous Needle Set Kits, BD™ Intraosseous Manual Driver Kits and...

BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world's largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/...

CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit ZARAGOZA, Spain and FRANKLIN LAKES, N.J., June 8, 2022 /PRNewswire/ --...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has appointed Simon Campion as executive vice president (EVP) and president of the...

Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate...

BD FACSDiscover™ S8 Cell Sorter with BD CellView™ Image Technology First to Combine Spectral Flow Cytometry with Sort-Capable Imaging FRANKLIN LAKES, N.J., June 3, 2022 /PRNewswire/ -- BD...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on...

Second Test for the BD COR™ MX to be CE Marked to IVD Directive FRANKLIN LAKES, N.J., May 26, 2022 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented...